These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 9253032)

  • 1. Uniform expression of cytotoxic molecules in anaplastic large cell lymphoma of null/T cell phenotype and in cell lines derived from anaplastic large cell lymphoma.
    Foss HD; Demel G; Anagnostopoulos I; Araujo I; Hummel M; Stein H
    Pathobiology; 1997; 65(2):83-90. PubMed ID: 9253032
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic cell antigen expression in anaplastic large cell lymphomas of T- and null-cell type and Hodgkin's disease: evidence for distinct cellular origin.
    Krenacs L; Wellmann A; Sorbara L; Himmelmann AW; Bagdi E; Jaffe ES; Raffeld M
    Blood; 1997 Feb; 89(3):980-9. PubMed ID: 9028330
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic large-cell lymphomas of T-cell and null-cell phenotype express cytotoxic molecules.
    Foss HD; Anagnostopoulos I; Araujo I; Assaf C; Demel G; Kummer JA; Hummel M; Stein H
    Blood; 1996 Nov; 88(10):4005-11. PubMed ID: 8916967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of cytotoxic proteins in peripheral T-cell and natural killer-cell (NK) lymphomas: association with extranodal site, NK or Tgammadelta phenotype, anaplastic morphology and CD30 expression.
    Kanavaros P; Boulland ML; Petit B; Arnulf B; Gaulard P
    Leuk Lymphoma; 2000 Jul; 38(3-4):317-26. PubMed ID: 10830738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytotoxic protein expression in natural killer cell lymphomas and in alpha beta and gamma delta peripheral T-cell lymphomas.
    Boulland ML; Kanavaros P; Wechsler J; Casiraghi O; Gaulard P
    J Pathol; 1997 Dec; 183(4):432-9. PubMed ID: 9496260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of cytotoxic molecules in intestinal T-cell lymphomas. The German Study Group on Intestinal Non-Hodgkin Lymphoma.
    Daum S; Foss HD; Anagnostopoulos I; Dederke B; Demel G; Araujo I; Riecken EO; Stein H
    J Pathol; 1997 Jul; 182(3):311-7. PubMed ID: 9349234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas.
    Dukers DF; ten Berge RL; Oudejans JJ; Pulford K; Hayes D; Miseré JF; Ossenkoppele GJ; Jaspars LH; Willemze R; Meijer CJ
    J Clin Pathol; 1999 Feb; 52(2):129-36. PubMed ID: 10396241
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of TIA-1+ cytolytic-type granules and other cytolytic lymphocyte-associated markers in CD30+ anaplastic large cell lymphomas (ALCL): correlation with morphology, immunophenotype, ultrastructure, and clinical features.
    Felgar RE; Salhany KE; Macon WR; Pietra GG; Kinney MC
    Hum Pathol; 1999 Feb; 30(2):228-36. PubMed ID: 10029454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gastrointestinal T cell lymphoma: predominant cytotoxic phenotypes, including alpha/beta, gamma/delta T cell and natural killer cells.
    Katoh A; Ohshima K; Kanda M; Haraoka S; Sugihara M; Suzumiya J; Kawasaki C; Shimazaki K; Ikeda S; Kikuchi M
    Leuk Lymphoma; 2000 Sep; 39(1-2):97-111. PubMed ID: 10975388
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytotoxic protein expression in non-Hodgkin's lymphomas and Hodgkin's disease.
    Kanavaros P; Vlychou M; Stefanaki K; Rontogianni D; Gaulard P; Pantelidaki E; Zois M; Darivianaki K; Georgoulias V; Boulland ML; Gorgoulis V; Kittas C
    Anticancer Res; 1999; 19(2A):1209-16. PubMed ID: 10368677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical, immunohistochemical and phenotypic features of aggressive nodal cytotoxic lymphomas, including alpha/beta, gamma/delta T-cell and natural killer cell types.
    Ohshima K; Suzumiya J; Sugihara M; Kanda M; Shimazaki K; Kawasaki C; Haraoka S; Kikuchi M
    Virchows Arch; 1999 Aug; 435(2):92-100. PubMed ID: 10599306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most primary cutaneous CD30-positive lymphoproliferative disorders have a CD4-positive cytotoxic T-cell phenotype.
    Kummer JA; Vermeer MH; Dukers D; Meijer CJ; Willemze R
    J Invest Dermatol; 1997 Nov; 109(5):636-40. PubMed ID: 9347791
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcutaneous panniculitic T-cell lymphoma is a tumor of cytotoxic T lymphocytes.
    Kumar S; Krenacs L; Medeiros J; Elenitoba-Johnson KS; Greiner TC; Sorbara L; Kingma DW; Raffeld M; Jaffe ES
    Hum Pathol; 1998 Apr; 29(4):397-403. PubMed ID: 9563791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of lysis by activated cytotoxic cells expressing perforin and granzyme-B genes and the protein TIA-1 in muscle biopsies of myositis.
    Cherin P; Herson S; Crevon MC; Hauw JJ; Cervera P; Galanaud P; Emilie D
    J Rheumatol; 1996 Jul; 23(7):1135-42. PubMed ID: 8823683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Primary CD30-positive cutaneous T-cell lymphomas and lymphomatoid papulosis frequently express cytotoxic proteins.
    Boulland ML; Wechsler J; Bagot M; Pulford K; Kanavaros P; Gaulard P
    Histopathology; 2000 Feb; 36(2):136-44. PubMed ID: 10672058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytotoxic activity of T- and NK-cell lymphoma cells is not dependent on a mature cytotoxic phenotype.
    Boehrer S; Schui DK; Chow KU; Hoelzer D; Mitrou PS; Weidmann E
    Leuk Lymphoma; 2002 Dec; 43(12):2363-8. PubMed ID: 12613525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Granzyme B and perforin lytic proteins are expressed in CD34+ peripheral blood progenitor cells mobilized by chemotherapy and granulocyte colony-stimulating factor.
    Berthou C; Marolleau JP; Lafaurie C; Soulié A; Dal Cortivo L; Bourge JF; Benbunan M; Sasportes M
    Blood; 1995 Nov; 86(9):3500-6. PubMed ID: 7579456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In situ detection of activated cytotoxic cells in follicular lymphomas.
    Leger-Ravet MB; Devergne O; Peuchmaur M; Solal-Celigny P; Brousse N; Gaulard P; Galanaud P; Emilie D
    Am J Pathol; 1994 Mar; 144(3):492-9. PubMed ID: 7510456
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NPM-ALK and the JunB transcription factor regulate the expression of cytotoxic molecules in ALK-positive, anaplastic large cell lymphoma.
    Pearson JD; Lee JK; Bacani JT; Lai R; Ingham RJ
    Int J Clin Exp Pathol; 2011 Jan; 4(2):124-33. PubMed ID: 21326808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nodal cytotoxic lymphoma spectrum: a clinicopathologic study of 66 patients.
    Kagami Y; Suzuki R; Taji H; Yatabe Y; Takeuchi T; Maeda S; Kondo E; Kojima M; Motoori T; Mizoguchi Y; Okamoto M; Ohnishi K; Yamabe H; Seto M; Ogura M; Koshikawa T; Takahashi T; Kurita S; Morishima Y; Suchi T; Nakamura S
    Am J Surg Pathol; 1999 Oct; 23(10):1184-200. PubMed ID: 10524519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.